Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2008 June;50(2) > Panminerva Medica 2008 June;50(2):129-37

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEWS  update on CARDIOLOGICAL ISSUES


Panminerva Medica 2008 June;50(2):129-37

Copyright © 2008 EDIZIONI MINERVA MEDICA

lingua: Inglese

Cell therapy for cardiac repair

Fine G. C., Liao R., Sohn R. L.

Cardiac Muscle Research Laboratory Cardiovascular Division, Department of Medicine Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USA


FULL TEXT  


Cardiovascular diseases remain the leading cause of morbidity and mortality in Western society. Among these diseases, congestive heart failure continues to be a significant health care burden. Recent medical and surgical advances in therapy have improved the quality and quantity of life for patients with heart failure. However, none of these therapies address the fundamental problem of loss of functional cardiomyocytes. Cell regeneration therapies have become an exciting potential treatment for heart failure and other cardiovascular diseases. This emerging therapeutic field has been pursued experimentally with both embryonic-derived stem cells and adult-derived progenitor cells. The identification of resident cardiac progenitor cells has propelled the field of cardiac regenerative biology forward at astonishing rates. This review will examine current findings of various stem and progenitor cells that have been proposed as potential sources for cardiac regeneration, and the recent therapeutic findings from preliminary clinical trials using some of these cell types for cardiovascular repair.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail